Trial Profile
Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2015 New trial record
- 01 Jan 2014 Interim results published in the Circulation Journal